Discover 2,221 paid clinical trials in Hayward, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 2,221
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
for
Advanced Malignant Solid Neoplasm,
Location: Palo Alto CA, San Francisco CA, Elk Grove CA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 0+
Code: NCT05564377
Phase 2, Recruiting
A Phase 1 Study of LY5830966 in Participants With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (PPV-MF), or Post-Essential Thrombocythemia Myelofibrosis (PET-MF) Who Have Been Failed by a Type I JAK2 Inhibitor (JAK2i)
for
Primary Myelofibrosis
Location: Palo Alto CA, Kansas City KS, Houston TX, St Louis MO,
Sponsor: Ajax Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT06343805
Phase 1, Recruiting
A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer
for
Carcinoma, Non-small-Cell Lung
Location: Stanford CA, Orange CA, La Jolla CA, Seattle WA,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT05498428
Phase 2, Recruiting
Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations
Location: Stanford CA, La Jolla CA, Salt Lake City UT, Gilbert AZ,
Sponsor: Opna Bio LLC
Sex: All
Age: 18+
Code: NCT06433947
Phase 1, Recruiting
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
for
Carcinoma, Non-Small-Cell Lung
Location: Palo Alto CA, Walnut Creek CA, Los Angeles CA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT06890598
Phase 3, Recruiting
A Study of D3S-001 Monotherapy or Combination Therapy in Subjects With Advanced Solid Tumors With a KRAS p.G12C Mutation
for
KRAS P.G12C
Location: Palo Alto CA, Orange CA, Denver CO, Houston TX,
Sponsor: D3 Bio (Wuxi) Co., Ltd
Sex: All
Age: 18+
Code: NCT05410145
Phase 1, Phase 2, Recruiting
A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer
for
Advanced Breast Cancer
Location: Palo Alto CA, San Francisco CA, Santa Monica CA,
Sponsor: Stemline Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06638307
Phase 1, Recruiting
B7-H3 Chimeric Antigen Receptor T Cells (B7-H3CART) in Recurrent Glioblastoma Multiforme
for
Brain and Nervous System
Location: Palo Alto CA
Sponsor: Stanford University
Sex: All
Age: 18+
Code: NCT05474378
Phase 1, Recruiting
GOLD: Brief Intervention to Reduce Anxiety and Promote Resilience in Families of Youth With Cancer
for
Cancer
Location: San Francisco CA
Sponsor: Stanford University
Sex: All
Age: 8 - 18
Code: NCT05415007
Recruiting
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
for
Neoplasms
Location: Stanford CA, San Francisco CA, Santa Monica CA,
Sponsor: Celgene
Sex: All
Age: 0+
Code: NCT03435796
Phase 2, Phase 3, Recruiting
A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma
for
Endometrial Adenocarcinoma
Location: Palo Alto CA, Sacramento CA, Santa Monica CA,
Sponsor: Acrivon Therapeutics
Sex: Female
Age: 18+
Code: NCT05548296
Phase 2, Recruiting
Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer
for
Renal Pelvis and Ureter Urothelial Carcinoma
Location: Palo Alto CA, La Jolla CA, San Diego CA, Nampa ID,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT04628767
Phase 2, Phase 3, Recruiting
Prospective Data Registry and Quality of Life Assessment of Patients Undergoing Radiotherapy With the RefleXion Medical Radiotherapy System
for
Cancer, Cancer Central Nervous System, Cancer Thoracic,
Location: Palo Alto CA, Duarte CA, Dallas TX, Pittsburgh PA,
Sponsor: RefleXion Medical
Sex: All
Age: 0+
Code: NCT05406167
Recruiting
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
for
Solid Tumors, Hematologic Malignancies
Location: Palo Alto CA, San Francisco CA, Bakersfield CA,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT03486873
Phase 3, Recruiting
Study of Targeted Therapy vs. Chemotherapy in Patients With Thyroid Cancer
for
Refractory Differentiated Thyroid Gland Carcinoma
Location: Palo Alto CA, Napa CA, Santa Rosa CA, Burbank CA,
Sponsor: ECOG-ACRIN Cancer Research Group
Sex: All
Age: 18+
Code: NCT06475989
Phase 3, Recruiting
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
for
Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum
Location: Palo Alto CA, Martinez CA, Vallejo CA, Stockton CA,